CASIA WHITNEY: Open Payments
NPI 1760764682 · ROCHESTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,300 in 82 payments from 20 companies in 2025. Trend: 2023 $966 · 2024 $1,146 · 2025 $1,300
Food & beverage: $1,151Education: $149
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $272 |
| Novo Nordisk Inc | 16 | $222 |
| Astellas Pharma US Inc | 3 | $155 |
| Amgen Inc. | 6 | $112 |
| PFIZER INC. | 4 | $82 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $69 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $64 |
| Abbott Laboratories | 2 | $44 |
| Verona Pharma, Inc. | 2 | $42 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $33 |
Products named: VRAYLAR, UBRELVY, Ozempic, Rybelsus, JARDIANCE, XIFAXAN, OTEZLA, QULIPTA.
Industry payments across NY — which companies pay providers there.
